Tevano Systems Holdings Inc. (TEVNF)
USD 0.0
(-99.76%)
USD 0.0
(-99.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | - CAD | -100.0% |
| 2022 | 123.81 Thousand CAD | -75.18% |
| 2021 | 498.94 Thousand CAD | -48.02% |
| 2020 | 959.86 Thousand CAD | 7509.22% |
| 2019 | -12.95 Thousand CAD | 63.29% |
| 2018 | -35.28 Thousand CAD | -102.27% |
| 2017 | 1.55 Million CAD | 19.24% |
| 2016 | 1.3 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2023 FY | - CAD | -100.0% |
| 2023 Q1 | 149.54 Thousand CAD | 20.78% |
| 2023 Q4 | - CAD | 100.0% |
| 2023 Q2 | 151.77 Thousand CAD | 1.49% |
| 2023 Q3 | -15 Thousand CAD | -109.89% |
| 2022 Q4 | 123.81 Thousand CAD | 55.08% |
| 2022 Q2 | 1.06 Million CAD | 20.97% |
| 2022 Q1 | 884.11 Thousand CAD | 77.2% |
| 2022 FY | 123.81 Thousand CAD | -75.18% |
| 2022 Q3 | 79.83 Thousand CAD | -92.53% |
| 2021 Q3 | -1.29 Million CAD | 0.0% |
| 2021 FY | 498.94 Thousand CAD | -48.02% |
| 2021 Q4 | 498.94 Thousand CAD | 138.55% |
| 2020 FY | -21.4 Thousand CAD | 7509.22% |
| 2019 FY | -12.95 Thousand CAD | 63.29% |
| 2018 FY | -35.28 Thousand CAD | -102.27% |
| 2017 FY | 1.55 Million CAD | 19.24% |
| 2016 FY | 1.3 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 100.0% |
| Ansell Limited | -54.99 Million USD | 100.0% |
| Ansell Limited | -55.1 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | -36.49 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -105.1 Thousand USD | 100.0% |
| Psykey, Inc. | 634.59 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| Encision Inc. | 1.29 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
| Innovative MedTech Inc. | 1.76 Million USD | 100.0% |
| LifePoint, Inc. | -3.26 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -43.3 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -1.03 Million USD | 100.0% |
| SmileDirectClub, Inc. | 778.67 Million USD | 100.0% |
| Sector 10, Inc. | 163 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.0% |
| SheerVision, Inc. | 57.34 Thousand USD | 100.0% |
| United Health Products, Inc. | 660.56 Thousand USD | 100.0% |
| Vasamed, Inc. | 22.12 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 100.0% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 100.0% |